Federal Supply Schedule 36F79721D0260
Award Date
9/30/21
Last Date to Order
9/29/26
Federal Agency
Veterans Integrated Service Network 12
Awardee
Astellas Pharma US, Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
This federal contract IDV is a Blanket Purchase Agreement (BPA) awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Astellas Pharma US, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The BPA was established against the VA's Federal Supply Schedule contract for drugs and pharmaceuticals, and has a ceiling value of $296,500 through October 2025. The BPA is for the procurement of the oncology drugs XTANDI and XOSPATA. This supports the VA's healthcare...
The Department of Veterans Affairs (VA) awarded a $19.3 million Federal Supply Schedule (FSS) contract to Servier Pharmaceuticals LLC, a for-profit pharmaceutical company, to provide drugs, pharmaceuticals, and hematology-related products. The FSS-61-IB contract has a period of performance through September 2025 and does not include any set-aside designations. Under this FSS contract, the VA has placed firm-fixed price delivery orders for Servier's specialty oncology medications, such as...
This Federal Supply Schedule (FSS) contract with the U.S. Department of Veterans Affairs (VA) was awarded to Taiho Oncology, Inc., a foreign-owned, for-profit manufacturer of goods. The contract, valued at a ceiling of $119,747,310.00, is for the supply of Drugs, Pharmaceuticals, & Hematology Related Products (FSS-61-IB) and has a period of performance through March 31, 2027. As a Federal Supply Schedule contract, this vehicle allows the VA and other federal agencies to procure the awarded...
This is a Federal Supply Schedule (FSS) contract awarded by the U.S. Department of Veterans Affairs (VA) to Acerus Pharmaceuticals Corporation. The contract, valued up to $750,000.00, is for the procurement of pharmaceuticals, drugs, and hematology-related products under FSS Schedule 65 I B. The contract has a period of performance from May 15, 2021, to May 14, 2026. As an FSS contract, this is a multiple-award vehicle that provides federal agencies with a streamlined purchasing process to...
The U.S. Department of Veterans Affairs (VA) awarded a $10 million Blanket Purchase Agreement (BPA) to Servier Pharmaceuticals LLC, a for-profit pharmaceutical company, to provide the specialty oncology medications asparlas and oncaspar over a five-year period. This single-award BPA was issued against Servier's existing Federal Supply Schedule (FSS) contract for pharmaceuticals and drugs. The VA has placed several fixed-price call orders against this BPA for delivery of asparlas and oncaspar...
The U.S. Department of Veterans Affairs (VA) has awarded a single-award Blanket Purchase Agreement (BPA) to Ferring Pharmaceuticals Inc., a for-profit manufacturer of pharmaceutical goods, under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The $5.96 million BPA, with a period of performance through March 2026, enables the VA to procure the drug Adstiladrin (nadofaragene firadenovec), a treatment for genitourinary cancers, to support the provision of healthcare services to...
The Department of Veterans Affairs (VA) awarded a Federal Supply Schedule (FSS) contract, valued at up to $3.5 million, to Calliditas Therapeutics US Inc., a foreign-owned, for-profit pharmaceutical company. The contract, under the Pharmaceuticals and Drugs (FSS-61-IB) schedule, facilitates the procurement of TARPEYO, an innovative treatment for uncontrolled protein in urine due to primary immunoglobulin A nephropathy, a serious renal condition impacting some veterans. In addition to the FSS...
This Federal Supply Schedule (FSS) contract, awarded by the Department of Veterans Affairs (VA) to Exela Pharma Sciences LLC, is for the procurement of pharmaceuticals, drugs, and hematology-related products under FSS-61-IB. The contract has a ceiling value of $3,030,000.00 and a period of performance through September 28, 2024. As a multiple-award schedule contract, this FSS allows the VA and other eligible federal agencies to issue task orders for a wide range of pharmaceutical and drug...
This Federal Supply Schedule (FSS) contract was awarded by the Department of Veterans Affairs (VA) to Ascend Therapeutics US LLC, a foreign-owned for-profit organization. The $25,000 interim agreement is under FSS Schedule 65 I B for Drugs, Pharmaceuticals, & Hematology Related Products, with a period of performance through September 14, 2023. As a multiple award contract, this FSS provides the VA with a pre-negotiated list of products and services that can be ordered as needed. The scope of...
This Federal Supply Schedule (FSS) contract, awarded by the U.S. Department of Veterans Affairs (VA) to Nobelpharma America, LLC, a foreign-owned, self-certified small disadvantaged business, is for the delivery of pharmaceutical and hematology-related products under Federal Supply Class 65 I B. The contract has a ceiling value of $225,000 and a period of performance through May 2028. In addition to the FSS contract, Nobelpharma America, LLC holds a single-award Blanket Purchase Agreement...